From: The fraction of life years lost after diagnosis (FLYLAD): a person-centred measure of cancer burden
 | Localised at diagnosis | Regional spread at diagnosis | Distant/Unknown spread at diagnosis | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aboriginal | Matched non-Aboriginal# | Aboriginal | Matched non-Aboriginal# | Aboriginal | Matched non-Aboriginal# | |||||||||||||||||||
N | % | Mean | 95% CIs | N | % | Mean | 95% CIs | N | % | Mean | 95% CIs | N | % | Mean | 95% CIs | N | % | Mean | 95% CIs | N | % | Mean | 95% CIs | |
Risk | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Age at diagnosis | 289 | 100.0% | 58.4 | 56.5–60.3 | 390 | 100.0% | 57.8 | 56.2–59.3 | 155 | 100.0% | 55.5 | 53.2–57.8 | 132 | 100.0% | 57.9 | 55.4–60.5 | 333 | 100.0% | 58.1 | 56.4–59.8 | 255 | 100.0% | 59.8 | 57.9–61.7 |
LYAR |  |  | 30.4 | 28.7–32.2 |  |  | 30.9 | 29.5–32.4 |  |  | 32.8 | 30.7–34.9 |  |  | 30.7 | 28.4–33.0 |  |  | 30.6 | 29.1–32.1 |  |  | 29.1 | 27.4–30.8 |
Loss | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Cancer deaths* | 101 | 34.9% | 65.9 | 63.0–68.9 | 100 | 25.6% | 64.9 | 61.6–68.2 | 93 | 60.0% | 58.9 | 56.1–61.7 | 59 | 44.7% | 63.1 | 59.6–66.7 | 267 | 80.2% | 60.8 | 59.1–62.6 | 181 | 71.0% | 63.2 | 61.1–65.2 |
YLLcancer |  |  | 8.3 | 6.7–9.9 |  |  | 6.3 | 5.0–7.6 |  |  | 17.8 | 15.1–20.6 |  |  | 11.6 | 9.0–14.2 |  |  | 22.5 | 20.8–24.3 |  |  | 18.5 | 16.6–20.4 |
Fraction of loss: risk | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
FLYLADcancer |  |  | 0.30 | 0.25–0.35 |  |  | 0.22 | 0.18–0.26 |  |  | 0.56 | 0.49–0.64 |  |  | 0.41 | 0.33–0.49 |  |  | 0.77 | 0.73–0.81 |  |  | 0.68 | 0.62–0.73 |